MBBS, FRCPA, FRACP
Special clinical interest
Stem cell transplantation and cellular therapy, malignant haematology
Blood disorders including acute and chronic leukaemias, lymphoma, myeloma, myeloproliferative disorders and myelodysplastic syndromes
Dr Adrian Selim is an Australian-trained haematologist with subspecialist fellowships in stem cell transplantation and cellular therapy. He is committed to providing patients and their loved ones with ample information and support and treats every patient with respect and empathy. Individual patient management is tailored for every case according to their individual goals and needs.
He is a fellow of both the Royal Australasian College of Physicians (FRACP) and the Royal College of Pathologists of Australasia (FRCPA). His clinical experience covers a wide range of malignant and non-malignant blood disorders including acute and chronic leukaemias, lymphoma, myeloma, myeloproliferative disorders and myelodysplastic syndromes.
Dr Adrian Selim is a haematologist with extensive expertise in malignant haematology. He completed dual clinical and laboratory haematology training in Sydney’s Eastern hospital network in 2017. Following this, he undertook a bone marrow transplant fellowship at the Bristol Royal Infirmary, United Kingdom.
Research, Awards and Teaching Interests
In 2019, Dr Selim returned to Australia to join the prestigious Peter MacCallum Cancer Centre in Melbourne as their first Cell Therapies fellow. During this two year fellowship he gained extensive experience in novel immunotherapies, particularly chimeric antigen receptor T-cell therapy (CAR-T), as well as a strong clinical research foundation.
Affiliations & Memberships
- European Haematology Association (EHA)
- Australasian Lymphoma and Leukaemia Group (ALLG)
- eviQ Cellular Therapies Reference Committee
- Royal Australasian College of Physicians (RACP)
- Royal College of Pathologist of Australasia (RCPA